Why should patent-rich companies value their patents? Because, in many cases, the majority of a company’s value lies in its intellectual property. If you can’t value your patents, you won’t get the values you deserve when negotiating capital raises, patent sales, and licensing agreements of the sales of companies.
David Wanetick discusses how factors such as claims breadth, priority dates, ease of detecting infringement, overcoming invalidity attacks, prior art searches, forward citations, prosecution histories, litigation experience of the patent attorney, and examiners’ allowance rates impact patent value.
This session addresses questions such as:
How many valuation methods should be used when valuing patents? How can one make use of their varying conclusions? How can you value a provisional patent application? How can patents enable companies to prosper when they are subject to trade bans? Why might venture capitalists prohibit their portfolio companies from enforcing their patents against infringers?
Gain incredible insights into patent valuation from this podcast.
David Wanetick is the CEO of IncreMental Advantage and a Managing Director at JD Merit. David has valued thousands of patents. His clients include Fortune 50 companies, emerging growth companies, mid-sized companies, tech transfer offices, national laboratories, venture capital funds, and private equity funds. He runs the Certified Patent Valuation Analyst designation and is the author of seven books.
Link for David Wanetick: